NCT03925246 Efficacy of Nivolumab for Recurrent IDH Mutated High-Grade Gliomas Status COMPLETED Phase PHASE2
NCT03718767 Nivolumab in Patients With IDH-Mutant Gliomas With and Without Hypermutator Phenotype Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03690869 REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma Status TERMINATED Phase PHASE1/PHASE2
NCT03605550 A Phase 1b Study of PTC596 in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma and High Grade Glioma Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT03411408 Accelerated Hypofractionated Intensity - Modulated Radiotherapy After Hyperbaric Oxygenation for Recurrent High Grade Glioma. Status UNKNOWN Phase NA
NCT03392545 Combination of Immunization and Radiotherapy for Malignant Gliomas (InSituVac1) Status UNKNOWN Phase PHASE1
NCT03355794 A Study of Ribociclib and Everolimus Following Radiation Therapy in Children With Newly Diagnosed Non-biopsied Diffuse Pontine Gliomas (DIPG) and RB+ Biopsied DIPG and High Grade Gliomas (HGG) Status COMPLETED Phase PHASE1
NCT03352427 Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations Status TERMINATED Phase PHASE2
NCT03334305 Adoptive Cellular Therapy in Pediatric Patients With High-grade Gliomas Status TERMINATED Phase PHASE1
NCT03294434 Predicting Sites of Tumour Progression in the Invasive Margin of Glioblastomas (PRaM-GBM Study) Status COMPLETED Phase N/A
NCT02970448 Expedited Laser Interstitial Thermal Therapy + Chemoradiation For Newly Diagnosed High Grade Gliomas Status COMPLETED Phase EARLY_PHASE1
NCT02885324 Pilot Study of Cabozantinib for Recurrent or Progressive Central Nervous System Tumors in Children Status TERMINATED Phase PHASE2
NCT02655601 Trial of Newly Diagnosed High Grade Glioma Treated With Concurrent Radiation Therapy, Temozolomide and BMX-001 Status COMPLETED Phase PHASE1/PHASE2
NCT02607124 A Phase I/II Study of Ribociclib,a CDK4/6 Inhibitor, Following Radiation Therapy Status TERMINATED Phase PHASE1/PHASE2
NCT02500459 Topotecan in Glioma Undergoing A Clinically-Indicated Surgical Resection Status TERMINATED Phase EARLY_PHASE1
NCT02041611 Prospective Evaluation of T-cell Immune Status in Patients With Newly Diagnosed High Grade Gliomas Status COMPLETED Phase NA
NCT02022644 Study of Convection-Enhanced, Image-Assisted Delivery of Liposomal-Irinotecan In Recurrent High Grade Glioma Status COMPLETED Phase PHASE1